Mayo Clinic study identifies predictors of smoking cessation

May 13, 2001

ROCHESTER, MINN. -- A multi-center study led by researchers at Mayo Clinic's Nicotine Dependence Center finds that men tend to be more successful at stopping smoking than women, and that the first two weeks of abstinence are critical in predicting long-term cessation.

The study, published in the May issue of Chest, also shows that the non-nicotine pill bupropion is an effective stop-smoking aid for all types of patients.

Conducted at Mayo Clinic, Palo Alto Center for Pulmonary Disease Prevention and West Virginia University, the research focused on 615 smokers who were randomly assigned to receive the drug bupropion or placebo. The goal of the study was to identify factors that contribute to a patient's success or failure in stopping smoking.

"By identifying smokers who are more likely to succeed or fail with bupropion therapy, treatment decisions can be made that might increase the patient's likelihood of stopping," says Lowell Dale, M.D., associate director of the Mayo Clinic Nicotine Dependence Center and principal author of the study. "We can use this study's findings to determine who should receive a brief behavioral intervention and who might need more intense therapy."

Several characteristics of smokers predicted greater rates of abstinence:
* Gender -- Male gender is predictive of a better outcome.
* Previous abstinence from smoking -- People who have never quit or who have quit for at least a month are more likely to succeed.
* Average number of cigarettes per day -- Lighter smokers are more likely to stop.
* Bupropion -- People on a higher dose were more successful.
* Age -- Older people stopped at higher rates.
* Household smoking -- People living in smoke-free households were more successful.
* Stop attempts -- People with a greater number of stop attempts did better.


"Interestingly, male gender predicted greater abstinence rates than did female gender," says Dr. Dale. "While some studies have not found a gender difference in ability to stop smoking, other studies have noted that women have more trouble quitting than men. This has been attributed to women's greater concerns about weight gain when they stop. Women also have higher rates of depression than men and are more likely to use smoking as a means of managing mood."

Another key finding: abstinence during the first two weeks after stopping was predictive of long-term success.

"Patients and physicians must put more effort into those first few weeks of treatment," notes Dr. Dale. "The key is to aggressively treat patients during the first weeks of their stop attempt. This may need to include counseling, bupropion and nicotine replacement in order to help patients increase their likelihood of quitting for good."
-end-
Note: The prescription drug bupropion SR (Zyban) used in this study is manufactured by Glaxo-SmithKline. GSK provided a grant for this research.

Shelly Plutowski
507-284-5005 (days)
507-284-2511 (evenings)
e-mail: newsbureau@mayo.edu

Mayo Clinic

Related Smoking Articles from Brightsurf:

Smoking rates falling in adults, but stroke survivors' smoking rates remain steady
While the rate of Americans who smoke tobacco has fallen steadily over the last two decades, the rate of stroke survivors who smoke has not changed significantly.

What is your risk from smoking? Your network knows!
A new study from researchers at Penn's Annenberg School for Communication found that most people, smokers and non-smokers alike, were nowhere near accurate in their answers to questions about smoking's health effects.

Want to quit smoking? Partner up
Kicking the habit works best in pairs. That's the main message of a study presented today at EuroPrevent 2019, a scientific congress of the European Society of Cardiology (ESC).

Smoking and mortality in Asia
In this analysis of data from 20 studies conducted in China, Japan, South Korea, Singapore, Taiwan and India with more than 1 million participants, deaths associated with smoking continued to increase among men in Asia grouped by the years in which they were born.

Predictors of successfully quitting smoking among smokers registered at the quit smoking clinic at a public hospital in northeastern Malaysia
In the current issue of Family Medicine and Community Health, Nur Izzati Mohammad et al. consider how cigarette smoking is one of the risk factors leading to noncommunicable diseases such as cardiovascular and respiratory system diseases and cancer.

Restaurant and bar smoking bans do reduce smoking, especially among the highly educated
Smoking risk drops significantly in college graduates when they live near areas that have completely banned smoking in bars and restaurants, according to a new study in the American Journal of Epidemiology.

How the UK smoking ban increased wellbeing
Married women with children reported the largest increase in well-being following the smoking bans in the UK in 2006 and 2007 but there was no comparable increase for married men with children.

Smoking study personalizes treatment
A simple blood test is allowing Vanderbilt University Medical Center (VUMC) researchers to determine which patients should be prescribed varenicline (Chantix) to stop smoking and which patients could do just as well, and avoid side effects, by using a nicotine patch.

A biophysical smoking gun
While much about Alzheimer's disease remains a mystery, scientists do know that part of the disease's progression involves a normal protein called tau, aggregating to form ropelike inclusions within brain cells that eventually strangle the neurons.

A case where smoking helped
A mutation in the hemoglobin of a young woman in Germany was found to cause her mild anemia.

Read More: Smoking News and Smoking Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.